Cargando…
Cardiac manifestations in patients with classical or cardiac subtype of Fabry disease
BACKGROUND: Fabry disease (FD) is an X-linked lysosomal storage disorder engendered by a deficiency of the enzyme α-galactosidase A, leading to systemic accumulation of glycolipids. Studies have reported that the cardiac subtype of FD has a later onset and minimal extracardiac involvement. However,...
Autores principales: | Wang, Wei-Ting, Sung, Shih-Hsien, Liao, Jo-Nan, Hsu, Ting-Rong, Niu, Dau-Ming, Yu, Wen-Chung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478196/ https://www.ncbi.nlm.nih.gov/pubmed/32649415 http://dx.doi.org/10.1097/JCMA.0000000000000379 |
Ejemplares similares
-
Correlations between Endomyocardial Biopsies and Cardiac Manifestations in Taiwanese Patients with the Chinese Hotspot IVS4+919G>A Mutation: Data from the Fabry Outcome Survey
por: Hsu, Ting-Rong, et al.
Publicado: (2017) -
A comparison of central nervous system involvement in patients with classical Fabry disease or the later-onset subtype with the IVS4+919G>A mutation
por: Lee, Han-Jui, et al.
Publicado: (2017) -
Effects of enzyme replacement therapy for cardiac-type Fabry patients with a Chinese hotspot late-onset Fabry mutation (IVS4+919G>A)
por: Lin, Hsiang-Yu, et al.
Publicado: (2013) -
Current status of cardiac manifestations in Fabry disease and their treatment
por: Radulescu, Dan, et al.
Publicado: (2021) -
Left Ventricular Apical Aneurysm in Fabry Disease: Implications for Clinical Significance and Risk Stratification
por: Chang, Hao‐Chih, et al.
Publicado: (2022)